We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPI:JSECapitec Bank Holdings Limited Analysis

Data as of 2026-09-08 - not real-time

ZAC 470,800.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At ZAC 470,800.00, Capitec Limited shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 1.7%. Relative strength is 52.2 — neutral — and the MACD signal is bearish. The recent range runs from support at ZAC 456,523.00 up to resistance at ZAC 488,770.00.
On valuation the read is overvalued — earnings multiple of 32.4 versus a 16.2 sector average, above the peer group. The average analyst target implies 11.8% above today's level. Revenue is growing at 16.4% on a 39.7% profit margin. The 1.71% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 14.9%, a beta of 0.31 and a maximum drawdown of 14.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Capitec Bank stock is drawing attention as the South African retail lender nears a secondary listing

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 442431.88
  • MACD momentum is negative
  • RSI at 52.2 is in neutral territory

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 32.4 versus sector average of 16.2
  • Trading above the 200-day average of 442431.88
  • Analyst targets imply +11.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 32.4 versus sector average of 16.2
  • Analyst targets imply +11.8% versus the current price
  • Profit margin of 39.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth16.40%
Profit Margin39.68%
P/E Ratio32.4
ROE30.50%
ROA6.71%
P/B Ratio9.2
Op. Cash FlowZAC3.2B
Industry P/E16.2

Technical Analysis

TrendNeutral
RSI52.2
SupportZAC 456,523.00
ResistanceZAC 488,770.00
MA 20ZAC 469,922.40
MA 50ZAC 471,497.94
MA 200ZAC 442,431.88
MACDBearish
VolumeDecreasing
Fear & Greed Index93.36

Valuation

Fair ValueZAC 92,994.69
Target PriceZAC 526,122.20
Upside/Downside11.75%
GradeOvervalued
TypeGrowth
Dividend Yield1.71%

Risk Assessment

Beta0.31
Volatility14.93%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.